CRIS Current Research Information System

MARZOCCHI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.843
EU - Europa 3.481
AS - Asia 1.991
AF - Africa 305
SA - Sud America 15
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.646
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.833
GB - Regno Unito 1.007
CN - Cina 670
VN - Vietnam 554
DE - Germania 487
SE - Svezia 466
SG - Singapore 451
IT - Italia 433
UA - Ucraina 278
RU - Federazione Russa 209
IN - India 192
IE - Irlanda 176
FR - Francia 142
NG - Nigeria 92
TG - Togo 85
EE - Estonia 81
BG - Bulgaria 69
ZA - Sudafrica 69
CH - Svizzera 55
JO - Giordania 41
CI - Costa d'Avorio 34
IR - Iran 28
FI - Finlandia 25
SC - Seychelles 25
JP - Giappone 22
BE - Belgio 20
AU - Australia 8
CA - Canada 8
KR - Corea 8
BR - Brasile 7
NL - Olanda 7
UZ - Uzbekistan 4
AR - Argentina 3
AT - Austria 3
CL - Cile 3
GR - Grecia 3
LB - Libano 3
PL - Polonia 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ES - Italia 2
HK - Hong Kong 2
HU - Ungheria 2
MX - Messico 2
MY - Malesia 2
PH - Filippine 2
SA - Arabia Saudita 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
SI - Slovenia 1
TH - Thailandia 1
Totale 10.646
Salva come PNG Salva come JPEG
Città #
Southend 909
Fairfield 545
Chandler 467
Singapore 403
Ashburn 346
Santa Clara 277
Woodbridge 258
Seattle 251
Wilmington 251
Houston 245
Dong Ket 217
Ann Arbor 216
Princeton 209
Jacksonville 199
Cambridge 198
Dublin 173
Boardman 133
Abeokuta 92
Padova 92
Westminster 92
Nanjing 87
Lomé 85
Berlin 73
Turin 70
Sofia 68
Bremen 66
Beijing 63
Bologna 53
Bern 48
New York 43
Jinan 42
Amman 41
Nanchang 40
Saint Petersburg 39
Dearborn 35
San Diego 35
Abidjan 34
Milan 34
Shenyang 34
Mülheim 33
Changsha 32
Medford 31
Hebei 30
Helsinki 25
Mahé 23
Tokyo 21
Olalla 20
Brussels 19
Guangzhou 19
Jiaxing 18
Mountain View 18
Shanghai 18
Zhengzhou 18
Tianjin 17
Taizhou 15
Yubileyny 15
Lanzhou 14
Paris 14
Verona 14
Norwalk 13
Haikou 12
Los Angeles 12
Redwood City 12
Des Moines 11
Hangzhou 11
Ningbo 11
Hefei 10
Leawood 10
Pune 10
Taiyuan 10
Ardabil 9
Falkenstein 9
Fuzhou 9
Kuban 9
Redmond 9
Falls Church 8
Florence 8
Kunming 8
Monmouth Junction 8
Phoenix 8
Rome 8
San Venanzo 8
Zanjan 8
Andover 7
Columbus 7
Washington 7
Frankfurt am Main 6
Reggio Emilia 6
Shenzhen 6
Wuhan 6
Costa Mesa 5
London 5
Toronto 5
Xi'an 5
Changchun 4
Frankfurt Am Main 4
Lausanne 4
Munich 4
Rostock 4
San Francisco 4
Totale 7.297
Salva come PNG Salva come JPEG
Nome #
A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study. 213
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 197
[Cognitive and quality of life trajectory after either surgical or transcatheter aortic valve replacement in high-risk patients] 185
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 178
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. 172
A randomised comparison between clopidogrel 150 mg daily maintenance dose versus 75 mg in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention 171
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 169
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 163
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 163
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 162
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 154
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 154
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 149
Clinical value of multidetector CT coronary angiography as a preoperative screening test before non-coronary cardiac surgery 148
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 146
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 144
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 143
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 141
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 139
Brachiterapia coronarica per la ristenosi intrastent a carico di biforcazioni: follow up angiografico a 9 mesi. 139
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 138
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged ³ 75 years) 136
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 136
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 135
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 134
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 130
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 129
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 129
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 126
One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study 126
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 126
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 125
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 125
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 124
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 124
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. 124
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system 123
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access. 123
[Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study] 122
Preprocedural Levels of C-Reactive Protein and Leukocyte Counts Predict 9-Month Mortality After Coronary Angioplasty for the Treatment of Unprotected Left Main Coronary Artery Stenosis. 120
Effective and equivalent organ doses in patients undergoing coronary angiography and percutaneous coronary interventions 119
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 118
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 118
Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. 117
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 116
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 115
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 115
La rete per il trattamento dell’infarto miocardico acuto con sopraslivellamento del tratto ST in Italia. Risultati della rilevazione RETE IMA WEB 114
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 114
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 113
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 111
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 111
Ogni lungo viaggio inizia con un piccolo passo: Il Signor C e la cardiologia interventistica 110
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 109
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 109
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 109
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 107
The safety of drug-eluting stents. 107
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 104
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with tirofiban or Abciximab [FATA] trial) 104
Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. 102
Acute hand ischemia after radial intervention in patient with CREST-associated pulmonary hypertension: successful treatment with manual thromboaspiration. 102
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. 102
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 101
Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction 99
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 98
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 98
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 98
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 96
Predictors of 32P h brachytherapy failure in patients with high-risk in-stent restenosis 96
Prognostic significance of mean platelet volume on admission in unselected cohort of patients with non ST-segment elevation acute coronary syndrome 95
Description of an In-vitro of Stent Perfusion to Study Stent Thrombosis at Different Shear Rates 94
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 94
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 91
Ruolo del fattore tissutale circolante nel determinare la trombosi di stent in un sistema di perfusione in vitro. 89
Risk of stroke in patients with high on clopidrogel platelet reactivity to ADP after percutaneous coronary intervention: systematic review and meta-analysis 89
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 88
Coronary 32P beta Brachytherapy: our singleinstitution experience 87
Electrocardiographic pattern to enhance prediction of in-hospital cardiovascular death in patients with non ST elevation acute coronary syndrome 87
null 86
Valve-in-valve technique to manage acute paraprosthetic leak after transcatheter aortic valve implantation. 86
Displacement of calcium nodules of the native valve as a possible cause of left main occlusion following transcatheter aortic valve implantation. 85
Significant decrease of door-to-balloon time by direct transport from ambulance to cath lab 85
Predictors of beta-brachytherapy failure in patients with high-risk in-stent restenosis 80
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 79
False Positive Coronary Angiography Activation in a Primary Coronary Angioplasty Network: Does Direct Ambulance-based Access Influence The Prevalence Rate? 78
Predictors of complicated athero-thrombotic lesions and their prognostic significance in unselected patients with non ST-segment acute coronary syndrome 77
Risk of Adverse Cardiac and Bleeding Events Following Cardiac and Noncardiac Surgery in Patients With Coronary Stent: How Important Is the Interplay Between Stent Type and Time From Stenting to Surgery? 76
null 72
In the era of the valve-in-valve: is transcatheter aortic valve implantation (TAVI) in sutureless valves feasible? 69
Left Ventricular Function After ST-Elevation Myocardial Infarction in Patients Treated With Primary Coronary Angioplasty and Abciximab or Tirofiban: Insights From the Facilitated Angioplasty with Tirofiban or Abciximab (FATA) Randomized Trial 68
Emergency balloon aortic valvuloplasty in patients with critical aortic stenosis presenting with cardiogenic shock. 55
Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: The pacing versus no pacing (PNP) study 51
The conundrum of transient cortical blindness following coronary angiography. 30
Totale 10.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.069 0 0 0 0 0 0 0 335 324 181 95 134
2020/20211.388 276 101 18 78 9 78 20 68 120 70 62 488
2021/20221.903 251 99 119 173 139 109 29 100 58 151 344 331
2022/20232.280 211 324 136 279 220 154 47 148 396 54 200 111
2023/2024491 35 63 30 58 56 146 17 31 5 26 9 15
2024/20251.285 95 304 172 147 395 80 90 2 0 0 0 0
Totale 10.908